Seattle Genetics Inc. (SGEN) News Headlines

▮ More

Date

Headline

11/7/2019 8:08:24 AM Seattle Genetics Announces Multiple ADCETRIS Presentations

11/5/2019 8:06:58 AM Seattle Genetics, BeiGene Announce License Agreement For Advanced Preclinical Product Candidate For Treating Cancer

11/5/2019 12:19:44 AM Seattle Genetics Responds To Daiichi Sankyo's Declaratory Judgment Complaint

11/4/2019 11:56:59 PM Seattle Genetics Responds To Daiichi Sankyo's Complaint For Declaratory Judgment

10/29/2019 4:16:46 PM EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q3 Earnings Report

10/29/2019 4:07:51 PM Seattle Genetics Q3 Loss Per Share $0.55 Vs Loss $0.42 Last Year

10/22/2019 7:13:52 AM Healthcare Stocks That Hit New Highs (SGEN, RCEL, REPH,...)

10/22/2019 3:31:36 AM Odonate On The Move With CONTESSA, FDA Snubs CLSD, It's A Yes For AZN, VRTX

10/21/2019 7:23:48 AM Seattle Genetics Announces Positive Topline Results From HER2CLIMB Trial

10/21/2019 6:48:17 AM Seattle Genetics Reports Positive Topline Results From HER2CLIMB trial

9/17/2019 4:09:51 AM XLRN Pulls The Plug On FSHD Study, KPTI Well Funded, ACRS Up On Wart Trial Data

9/16/2019 8:12:36 AM Astellas Pharma: FDA Grants Priority Review For Enfortumab Vedotin - Quick Facts

9/16/2019 8:02:47 AM Seattle Genetics And Astellas: FDA Grants Priority Review For Enfortumab Vedotin BLA

7/17/2019 9:50:07 PM 5 Top Gainers In Healthcare Sector (SCPH, SGEN, ANIX…)

7/16/2019 4:38:50 PM EARNINGS SUMMARY: Details of Seattle Genetics Inc. Q2 Earnings Report

7/16/2019 4:05:52 PM Seattle Genetics Q2 Loss/share $0.49 Vs. Profit $0.47 Year Ago

7/16/2019 3:00:11 PM Seattle Genetics Q2 19 Earnings Conference Call At 4:30 PM ET

7/16/2019 8:40:20 AM Seattle Genetics, Astellas Submit BLA For Enfortumab Vedotin - Quick Facts

7/16/2019 8:19:27 AM Astellas And Seattle Genetics Announce Submission Of Biologics License Application To FDA For Enfortumab Vedotin

7/16/2019 8:09:39 AM Seattle Genetics, Astellas Announce Submission Of BLA For Enfortumab Vedotin